Home LiteratureArticle Details
PMID: 21717116 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study.

Diabetologia ·Vol. 54 ·No. 9 ·2011-09-00 ·Pages 2272-82

InterAct Consortium, Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, Kerrison N, Ekelund U, Barroso I, Panico S, Tormo MJ, Spranger J, Griffin S, van der Schouw YT, Amiano P, Ardanaz E, Arriola L, Balkau B, Barricarte A, Beulens JW, Boeing H, Bueno-de-Mesquita HB, Buijsse B, Chirlaque Lopez MD, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillan B, Deloukas P, Dorronsoro M, Drogan D, Froguel P, Gonzalez C, Grioni S, Groop L, Groves C, Hainaut P, Halkjaer J, Hallmans G, Hansen T, Huerta Castaño JM, Kaaks R, Key TJ, Khaw KT, Koulman A, Mattiello A, Navarro C, Nilsson P, Norat T, Overvad K, Palla L, Palli D, Pedersen O, Peeters PH, Quirós JR, Ramachandran A, Rodriguez-Suarez L, Rolandsson O, Romaguera D, Romieu I, Sacerdote C, Sánchez MJ, Sandbaek A, Slimani N, Sluijs I, Spijkerman AM, Teucher B, Tjonneland A, Tumino R, van der A DL, Verschuren WM, Tuomilehto J, Feskens E, McCarthy M, Riboli E, Wareham NJ

Abstract

Studying gene-lifestyle interaction may help to identify lifestyle factors that modify genetic susceptibility and uncover genetic loci exerting important subgroup effects. Adequately powered studies with prospective, unbiased, standardised assessment of key behavioural factors for gene-lifestyle studies are lacking. This case-cohort study aims to investigate how genetic and potentially modifiable lifestyle and behavioural factors, particularly diet and physical activity, interact in their influence on the risk of developing type 2 diabetes. Incident cases of type 2 diabetes occurring in European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts between 1991 and 2007 from eight of the ten EPIC countries were ascertained and verified. Prentice-weighted Cox regression and random-effects meta-analyses were used to investigate differences in diabetes incidence by age and sex. A total of 12,403 verified incident cases of type 2 diabetes occurred during 3.99 million person-years of follow-up of 340,234 EPIC participants eligible for InterAct. We defined a centre-stratified subcohort of 16,154 individuals for comparative analyses. Individuals with incident diabetes who were randomly selected into the subcohort (n = 778) were included as cases in the analyses. All prevalent diabetes cases were excluded from the study. InterAct cases were followed-up for an average of 6.9 years; 49.7% were men. Mean baseline age and age at diagnosis were 55.6 and 62.5 years, mean BMI and waist circumference values were 29.4 kg/m(2) and 102.7 cm in men, and 30.1 kg/m(2) and 92.8 cm in women, respectively. Risk of type 2 diabetes increased linearly with age, with an overall HR of 1.56 (95% CI 1.48-1.64) for a 10 year age difference, adjusted for sex. A male excess in the risk of incident diabetes was consistently observed across all countries, with a pooled HR of 1.51 (95% CI 1.39-1.64), adjusted for age. InterAct is a large, well-powered, prospective study that will inform our understanding of the interplay between genes and lifestyle factors on the risk of type 2 diabetes development.

MeSH Terms
Cohort Studies Diabetes Mellitus, Type 2/epidemiology,genetics,physiopathology Diet Europe/epidemiology Female Follow-Up Studies Genetic Predisposition to Disease/genetics Humans Incidence International Cooperation Life Style Male Middle Aged Motor Activity/physiology Prospective Studies Retrospective Studies Risk Factors
Authors & Affiliations
75 authors, click to expand affiliations / ORCID
InterAct Consortium
Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Box 285, Cambridge CB2 0QQ, UK e-mail: [email protected]
Langenberg C
Sharp S
Forouhi N G
Franks P W
Schulze M B
Kerrison N
Ekelund U
Barroso I
Panico S
Tormo M J
Spranger J
Griffin S
van der Schouw Y T
Amiano P
Ardanaz E
Arriola L
Balkau B
Barricarte A
Beulens J W J
Boeing H
Bueno-de-Mesquita H B
Buijsse B
Chirlaque Lopez M D
Clavel-Chapelon F
Crowe F L
de Lauzon-Guillan B
Deloukas P
Dorronsoro M
Drogan D
Froguel P
Gonzalez C
Grioni S
Groop L
Groves C
Hainaut P
Halkjaer J
Hallmans G
Hansen T
Huerta Castaño J M
Kaaks R
Key T J
Khaw K T
Koulman A
Mattiello A
Navarro C
Nilsson P
Norat T
Overvad K
Palla L
Palli D
Pedersen O
Peeters P H
Quirós J R
Ramachandran A
Rodriguez-Suarez L
Rolandsson O
Romaguera D
Romieu I
Sacerdote C
Sánchez M J
Sandbaek A
Slimani N
Sluijs I
Spijkerman A M W
Teucher B
Tjonneland A
Tumino R
van der A D L
Verschuren W M M
Tuomilehto J
Feskens E
McCarthy M
Riboli E
Wareham N J
References (32)
32 references, click to expand
  1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
    Diabetes Care. 2004 May;27(5):1047-53 PMID: 15111519
  2. Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity.
    J Appl Physiol (1985). 2007 Aug;103(2):682-92 PMID: 17463305
  3. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data.
    Diabetes. 2009 Feb;58(2):505-10 PMID: 19056611
  4. Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up.
    Diabetologia. 2007 Apr;50(4):703-10 PMID: 17268796
  5. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    N Engl J Med. 2006 Jul 20;355(3):241-50 PMID: 16855264
  6. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Diabetes Care. 2007 Sep;30(9):2258-63 PMID: 17536076
  7. Guilt beyond a reasonable doubt.
    Nat Genet. 2007 Jul;39(7):813-5 PMID: 17597768
  8. Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK.
    Lancet. 1996 Nov 9;348(9037):1264-8 PMID: 8909378
  9. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study.
    Arch Intern Med. 2002 Jan 14;162(1):82-9 PMID: 11784224
  10. Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition.
    Comput Methods Programs Biomed. 1999 Mar;58(3):251-66 PMID: 10094230
  11. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.
    Br J Cancer. 1999 Jul;80 Suppl 1:95-103 PMID: 10466767
  12. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
    Science. 2007 Jun 1;316(5829):1341-5 PMID: 17463248
  13. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
    Nat Genet. 2008 May;40(5):638-45 PMID: 18372903
  14. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
    BMJ. 2009 Mar 17;338:b880 PMID: 19297312
  15. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
    Diabet Med. 2007 Feb;24(2):200-7 PMID: 17257284
  16. Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain.
    Diabetologia. 2003 Jul;46(7):899-909 PMID: 12830379
  17. Genome-wide association studies: potential next steps on a genetic journey.
    Hum Mol Genet. 2008 Oct 15;17(R2):R156-65 PMID: 18852205
  18. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
    Science. 2007 Jun 1;316(5829):1331-6 PMID: 17463246
  19. Genome-wide association studies in type 2 diabetes.
    Curr Diab Rep. 2009 Apr;9(2):164-71 PMID: 19323962
  20. General and abdominal adiposity and risk of death in Europe.
    N Engl J Med. 2008 Nov 13;359(20):2105-20 PMID: 19005195
  21. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.
    Public Health Nutr. 2002 Dec;5(6B):1113-24 PMID: 12639222
  22. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.
    Diabetes. 2004 Jul;53(7):1782-9 PMID: 15220202
  23. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
    Cochrane Database Syst Rev. 2010 Oct 06;(10):CD007275 PMID: 20927756
  24. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Public Health Nutr. 2003 Jun;6(4):407-13 PMID: 12795830
  25. Incidence of type 2 diabetes in southern Spain (Pizarra Study).
    Eur J Clin Invest. 2008 Feb;38(2):126-33 PMID: 18226046
  26. A genome-wide association study identifies novel risk loci for type 2 diabetes.
    Nature. 2007 Feb 22;445(7130):881-5 PMID: 17293876
  27. Global estimates of the prevalence of diabetes for 2010 and 2030.
    Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 PMID: 19896746
  28. Diet and cancer--the European Prospective Investigation into Cancer and Nutrition.
    Nat Rev Cancer. 2004 Mar;4(3):206-15 PMID: 14993902
  29. Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study.
    Diabet Med. 2009 Dec;26(12):1212-9 PMID: 20002472
  30. Cohort studies and the genetics of complex disease.
    Nat Genet. 2009 Jan;41(1):5-6 PMID: 19112455
  31. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
    Nat Genet. 2007 Jun;39(6):770-5 PMID: 17460697
  32. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
    Science. 2007 Jun 1;316(5829):1336-41 PMID: 17463249
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
1432-0428
Published
2011-09-00
Epub
2011-00-30
Pages
2272-82
Language
English
Region
Germany
NLM ID
0006777
PMCID
PMC4222062
Subset
IM
Grants
CIHR · G0601261 · Canada
Medical Research Council · G1000143 · United Kingdom
Medical Research Council · MC_U106179473 · United Kingdom
Medical Research Council · MC_U106179471 · United Kingdom
Medical Research Council · G0401527 · United Kingdom
Wellcome Trust · 083270/083270/z · United Kingdom
Medical Research Council · MC_UP_A090_1006 · United Kingdom
Medical Research Council · G0601261 · United Kingdom
Cancer Research UK · United Kingdom
Medical Research Council · MC_EX_G0800783 · United Kingdom
Medical Research Council · MC_UP_A100_1003 · United Kingdom
Wellcome Trust · 090532 · United Kingdom
Medical Research Council · MC_U106179474 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]